Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848) |
---|
06/05/2002 | CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists |
06/04/2002 | US6399809 From malonic acid monoester amide |
06/04/2002 | US6399798 Method of preparing alkylated salicylamides |
05/30/2002 | WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
05/30/2002 | WO2002042248A2 Naphthalene derivatives |
05/30/2002 | WO2002014264A3 (hydroxyethyl)ureas as inhibitors of alzheimer's beta-amyloid production |
05/30/2002 | WO2001021160B1 Carboxymide and aniline derivatives as selective inhibitors of pathogens |
05/30/2002 | US20020065316 Citrullimycines, a process for their production and their use as pharmaceuticals |
05/30/2002 | CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
05/29/2002 | EP1209147A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient |
05/29/2002 | EP1208091A1 Benzophenones as inhibitors of reverse transcriptase |
05/23/2002 | WO2002040446A1 Glucagon antagonist/inverse agonist |
05/23/2002 | WO2002040445A1 Glucagon antagonists/inverse agonists |
05/23/2002 | WO2002040444A1 Glucagon antagonists/inverse agonists |
05/23/2002 | WO2002039967A1 Novel coupler for use in oxidative hair dyeing |
05/23/2002 | WO2001098235A3 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants |
05/23/2002 | US20020061916 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
05/23/2002 | CA2424723A1 Novel coupler for use in oxidative hair dyeing |
05/22/2002 | EP0966434B1 Aminophenol derivatives and their use in cosmetics |
05/22/2002 | EP0681575B1 Process for the preparation of Baccatin III analogs bearing new C2 and C4 functional groups |
05/22/2002 | CN1350565A Nucleators for crystallizable thermoplastic polymers |
05/22/2002 | CN1350452A Preventive or therapeutic drugs for diabetes |
05/21/2002 | US6392001 Process for the production of light-stable polyisocyanates containing allophanate groups |
05/21/2002 | US6391917 Analgesic |
05/21/2002 | CA2230750C Antiherpes peptidomimetic compounds |
05/16/2002 | WO2002038534A2 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases |
05/16/2002 | US20020058784 Generation of preferential compound; obtain sample of diamino acid such as 2,3 diaminopropionic acid, incubate with compound with free amino group, recover urein |
05/16/2002 | US20020058654 For therapy of uterine fibroids, endometriosis, polycystic ovarian disease, dysfunctional uterine bleeding, breast cancer and ovarian cancer; depletion of oocytes; spermatocyte depletion; for female and male contraception |
05/16/2002 | CA2428266A1 Substituted alkyldiamines as inhibitors of plasmepsin or related proteases |
05/15/2002 | EP1204408A2 An improved form of form i celiprolol hydrochloride |
05/15/2002 | CN1349521A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
05/15/2002 | CN1349519A Glucokinase activators |
05/14/2002 | US6388153 Chain transfer agents |
05/14/2002 | US6388094 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
05/14/2002 | US6387949 Substituted urea compounds useful in pain management |
05/10/2002 | WO2002036553A2 Substituted alkanoic acids |
05/08/2002 | EP1203765A2 Process for the synthesis of urea |
05/08/2002 | CN1348443A N-substituted-N'-substituted urea derivative and medicinal compositions containing the same |
05/07/2002 | US6384220 Antidiabetic agents increasing the expression of glucokinase (gk) to improve glucose tolerance; increase in glucose exposure coupled through gk in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition |
05/07/2002 | US6384174 Polyurethanes |
05/07/2002 | US6384075 Treating diseases in which mast cell dysfunction is involved |
05/02/2002 | WO2001081298A3 Cyclic carboxylic acids as integrin antagonists |
05/02/2002 | US20020052417 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
05/02/2002 | US20020052370 Including the treatment of female sexual dysfunction especially female sexual arousal disorder |
05/02/2002 | US20020052348 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
05/02/2002 | US20020052028 Bio-intermediates for use in the chemical synthesis of polyketides |
05/02/2002 | EP1201648A1 Carbamate derivatives and agricultural/horticultural bactericides |
05/02/2002 | EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor |
05/01/2002 | CN1347404A (-)-Verbenzone derivs. |
05/01/2002 | CN1347318A Inhibitors of IMPDH enzyme |
05/01/2002 | CN1083831C Novel tricyclic compounds and drug compositions contg. same |
04/30/2002 | US6380392 Complexes |
04/25/2002 | US20020049236 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
04/24/2002 | EP1198456A2 Potassium channel openers |
04/23/2002 | US6376546 Biphenyl-5-alkanoic acid derivatives and use thereof |
04/23/2002 | US6376538 Antiinflammatory agents; autoimmune diseases |
04/18/2002 | WO2002030915A2 Aryl-indane compounds for use as inhibitors of p-glycoprotein mediated transport |
04/18/2002 | WO2002030876A2 Cyclic carboxylic acids as integrin antagonists |
04/18/2002 | WO2002030875A1 Beta-amino acid derivatives as integrin receptor antagonists |
04/18/2002 | WO2002030874A2 Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
04/18/2002 | WO2002003995A3 Treatment of male sexual dysfunction |
04/18/2002 | US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes. |
04/18/2002 | US20020045749 Antibacterial agents |
04/18/2002 | CA2424951A1 Beta-amino acid derivatives as integrin receptor antagonists |
04/17/2002 | CN1344711A Combined prep. of ammonia and urea |
04/16/2002 | US6372933 Reacting benzoxazolinone with nucleophilic aniline derivative in presence of lewis acid to open oxazolinone ring to form phenyl urea compound |
04/11/2002 | WO2002028824A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
04/11/2002 | WO2002028820A1 Nitroso diphenylamine derivatives |
04/11/2002 | WO2001045678A3 Medicament, a method for its production and the use thereof |
04/11/2002 | US20020042517 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
04/11/2002 | US20020042512 Alpha-acyl- and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
04/11/2002 | CA2424684A1 Nitroso diphenylamine derivatives |
04/11/2002 | CA2424273A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
04/10/2002 | CN1344259A Processes and intermediates for prepn. of 1,3-diazin-b 6-ones and uracils |
04/10/2002 | CN1344247A Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4 |
04/09/2002 | US6369073 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
04/04/2002 | WO2002026701A2 Ionic liquids and their use as solvents |
04/04/2002 | WO2002004407A3 7-substituted tetracycline compounds |
04/04/2002 | WO2001094301A3 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
04/04/2002 | DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use |
04/03/2002 | EP1193249A1 Citrullimycines, a process for their production and their use as pharmaceuticals |
04/03/2002 | EP1047719B1 Mixtures containing diisocyanates with allophanate groups derived from alicyclic alcohols |
03/28/2002 | WO2002024635A2 Aminoalcohol derivatives |
03/28/2002 | WO2002024613A2 Resorcinol derivatives |
03/28/2002 | US20020038025 For therapy and prophylaxis of hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, parasite infections, gallstones, tumors and/or hyperproliferative disorders, diabetes |
03/28/2002 | US20020037905 N-phenyl-N'-(2-carboxyphenyl) urea, for example; chloride channel blockers; such as for treating bone metabolic disorders |
03/28/2002 | US20020037854 Use of at least one no synthase inhibitor for treating sensitive skin |
03/28/2002 | CA2423262A1 Resorcinol derivatives |
03/27/2002 | EP1190710A1 Preventive or therapeutic drugs for diabetes |
03/27/2002 | EP1189612A1 Vla-4 inhibitor compounds |
03/27/2002 | EP0832079B1 Anti-ischaemic hydroxylamine derivatives and pharmaceutical compositions |
03/26/2002 | US6362360 Sensitizers for insulin resistance and associated conditions dyslipidemia and hyperglycemia |
03/26/2002 | US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use |
03/21/2002 | WO2002022844A1 Optically active fluorophenylalanine derivative and process for producing the same |
03/21/2002 | WO2002022627A2 Ligands for metabotropic glutamate receptors |
03/21/2002 | WO2002022592A2 Substituted urea neuropeptide y y5 receptor antagonists |
03/21/2002 | WO2001055081A3 Esters of fatty acids and juvenoid alcohols, and a method of their preparation and use |
03/21/2002 | US20020035293 Process for the integrated preparation of ammonia and urea |
03/21/2002 | US20020035137 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors |
03/21/2002 | US20020035114 Substituted dimeric compounds |